Anna Sureda

2 ta ish

University of Barcelona

1. Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma

   Frederick L. Locke, David B. Miklos, Caron A. Jacobson +28

   Maqola20212 iqtibos

   ABIABI:AkademIndex/2026.other.319265

2. Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma

   Juan‐José Garcés, María‐Teresa Cedena, Noemí Puig +25

   Maqola20222 iqtibos

   ABIABI:AkademIndex/2026.other.480203